Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acthar in IgA Nephropathy With Nephrotic Range Proteinuria
NCT02382523Phase 4Withdrawn
- Sponsor
- Baylor College of Medicine
- Start
- Feb 2015
- Primary completion
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of repository corticotropin injection in IgA nephropathy (IgAN), sponsored by Baylor College of Medicine. Planned start Feb 2015; status: withdrawn.
02
Drugs
repository corticotropin injection
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT02382523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02382523.